2026;
Phan TK, Sheerin D, Shi B, Chua NK, Gummadi S, Dayton M, Mackiewicz L, Maluenda A, Ozkocak DC, Atkin-Smith GK, Peton N, Ang C-S, Audi O, Thinh Le Q, Tran TU, Tu T-KM, Tixeira R, Ashdown GW, Davidson KC, Fonseka P, Feltham R, Doerflinger M, Hulett MD, Coussens AK, Poon IKH. Efferocytosis of apoptotic bodies drives SARS-CoV-2 infection and macrophage inflammation. Nature Communications. 2026;:10.1038/s41467-026-74363-8
Verzier LH, Hesping E, Doerflinger M, Herold MJ, Boddey JA. Cas9-expressing HC-04 hepatocytes facilitate CRISPR-based analysis of Plasmodium falciparum sporozoite-host interactions. PLOS Genetics. 2026;22(5):10.1371/journal.pgen.1012137
M. Bader S, Scherer L, Bhandari R, Motyer AJ, Cooney JP, Mackiewicz L, Dayton M, Sheerin D, V. L. Romero D, Schaefer J, Pang J, Chen S, Schoffer K, Wang L, Jin X, Batey D, Yip RKH, Zaman I, Rajasekhar P, Gartner MJ, Wilcox S, Whitehead L, Georgy SR, Maluenda A, Davidson KC, Allison CC, Bowden R, Brinkmann K, Asselin-Labat M-L, Phipson B, Tanzer MC, Herold MJ, Samson AL, Vince JE, Strasser A, Pellegrini M, Doerflinger M. Non-apoptotic caspase-8 is critical for orchestrating exaggerated inflammation during severe SARS-CoV-2 infection. Nature Communications. 2025;16(1):10.1038/s41467-025-65098-z
Kleeman EA, Gubert C, Reisinger SN, Davidson KC, Lu D, Dayton M, Mackiewicz L, Masson BA, Adithya P, Garnham AL, Stathatos G, O’Bryan MK, R. Muralitharan R, Marques FZ, Li S, Liao H, McLaughlin S, Keough ET, Wheeler MY, Kiridena P, Doerflinger M, Pellegrini M, Hannan AJ. Paternal SARS-CoV-2 infection impacts sperm small noncoding RNAs and increases anxiety in offspring in a sex-dependent manner. Nature Communications. 2025;16(1):10.1038/s41467-025-64473-0
Cooney JP, Hirons A, Jansz N, Allison CC, Hickey P, Teh CE, Tan T, Dagley LF, Yousef J, Yurick D, Khoury G, Preston SP, Arandjelovic P, Davidson KC, Williams LJ, Bader SM, Wang L, Bhandari R, Mackiewicz L, Dayton M, Clow W, Faulkner GJ, Gray DH, Einsiedel L, Purcell DFJ, Doerflinger M, Pellegrini M. Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo. Cell. 2025;188(18):10.1016/j.cell.2025.06.023
Deepagan VG, Ma X, Bazregari F, Pang J, Schaefer J, Hildebrand JM, Dempsey RK, Doerflinger M, Baldwin CA, Schmidt FI, Murphy JM, Salvamoser R, Vince JE. Lipid nanoparticle-delivered intrabodies for inhibiting necroptosis and pyroptosis. Biochemical Journal. 2025;482(16):10.1042/bcj20253191
Shojaee F, Azadian E, Wong MX, Ma X, Rickard J, Pang J, Hall C, Kueh AJ, Masters SL, Rioja I, Prinjha RK, Doerflinger M, Lawlor KE, Rashidi M, Vince JE. NLRP3 inflammasome–driven hemophagocytic lymphohistiocytosis occurs independent of IL-1β and IL-18 and is targetable by BET inhibitors. Science Advances. 2025;11(28):10.1126/sciadv.adv0079
M. Bader S, Scherer L, Schaefer J, Cooney JP, Mackiewicz L, Dayton M, Georgy SR, Davidson KC, Allison CC, Herold MJ, Strasser A, Pellegrini M, Doerflinger M. IL-1β drives SARS-CoV-2-induced disease independently of the inflammasome and pyroptosis signalling. Cell Death & Differentiation. 2025;32(7):10.1038/s41418-025-01459-x
Renz A, Hohner M, Jami R, Breitenbach M, Josephs-Spaulding J, Dürrwald J, Best L, Dulière V, Mialon C, Bader SM, Marinos G, Leonidou N, Cabreiro F, Pellegrini M, Doerflinger M, Rosa-Calatrava M, Pizzorno A, Dräger A, Schindler M, Kaleta C. Metabolic modeling elucidates phenformin and atpenin A5 as broad-spectrum antiviral drugs against RNA viruses. Communications Biology. 2025;8(1):10.1038/s42003-025-08148-y
